All news from Nephrology

Lasting Effects from Head Injuries at Younger Age than Expected

There have been more and more cases confirming that repeated hits to the head have lifelong consequences for professional football players, but a new study by Orlando Health in collaboration with the Concussion Neuroimaging Consortium finds evidence of lasting effects from head injuries at a much younger age than expected. The study tested biomarkers in the blood called microRNA's and found that the college football players had elevated levels of these biomarkers that indicate concussions before the season even started.

Lorbrena Approved for ALK-positive Metastatic NSCLC

Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved LORBRENA [lor-BREN-ah] (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for patients with ALK-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.